Literature DB >> 17353345

The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor.

Babs O Fabriek1, Machteld M J Polfliet, Rianka P M Vloet, Roel C van der Schors, Antoon J M Ligtenberg, Lehn K Weaver, Christiaan Geest, Kenjiro Matsuno, Søren K Moestrup, Christien D Dijkstra, Timo K van den Berg.   

Abstract

Erythropoiesis occurs in erythroblastic islands, where developing erythroblasts closely interact with macrophages. The adhesion molecules that govern macrophage-erythroblast contact have only been partially defined. Our previous work has implicated the rat ED2 antigen, which is highly expressed on the surface of macrophages in erythroblastic islands, in erythroblast binding. In particular, the monoclonal antibody ED2 was found to inhibit erythroblast binding to bone marrow macrophages. Here, we identify the ED2 antigen as the rat CD163 surface glycoprotein, a member of the group B scavenger receptor cysteine-rich (SRCR) family that has previously been shown to function as a receptor for hemoglobin-haptoglobin (Hb-Hp) complexes and is believed to contribute to the clearance of free hemoglobin. CD163 transfectants and recombinant protein containing the extracellular domain of CD163 supported the adhesion of erythroblastic cells. Furthermore, we identified a 13-amino acid motif (CD163p2) corresponding to a putative interaction site within the second scavenger receptor domain of CD163 that could mediate erythroblast binding. Finally, CD163p2 promoted erythroid expansion in vitro, suggesting that it enhanced erythroid proliferation and/or survival, but did not affect differentiation. These findings identify CD163 on macrophages as an adhesion receptor for erythroblasts in erythroblastic islands, and suggest a regulatory role for CD163 during erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353345     DOI: 10.1182/blood-2006-08-036467

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin.

Authors:  Melissa M Rhodes; Prapaporn Kopsombut; Maurice C Bondurant; James O Price; Mark J Koury
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 2.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

3.  Identification and transcriptome analysis of erythroblastic island macrophages.

Authors:  Wei Li; Yaomei Wang; Huizhi Zhao; Huan Zhang; Yuanlin Xu; Shihui Wang; Xinhua Guo; Yumin Huang; Shijie Zhang; Yongshuai Han; Xianfang Wu; Charles M Rice; Gang Huang; Patrick G Gallagher; Avital Mendelson; Karina Yazdanbakhsh; Jing Liu; Lixiang Chen; Xiuli An
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

4.  CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing.

Authors:  Marianne Jensby Nielsen; Christian Brix Folsted Andersen; Søren Kragh Moestrup
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

5.  Maea expressed by macrophages, but not erythroblasts, maintains postnatal murine bone marrow erythroblastic islands.

Authors:  Qiaozhi Wei; Philip E Boulais; Dachuan Zhang; Sandra Pinho; Masato Tanaka; Paul S Frenette
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

6.  The secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesis.

Authors:  Zhiying Zou; David R Enis; Hung Bui; Eugene Khandros; Vinayak Kumar; Zoltan Jakus; Christopher Thom; Yiqing Yang; Veerpal Dhillon; Mei Chen; Minmin Lu; Mitchell J Weiss; Mark L Kahn
Journal:  Blood       Date:  2013-02-20       Impact factor: 22.113

7.  Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.

Authors:  Hiromi Kanno; Hiroshi Nishihara; Lei Wang; Sayaka Yuzawa; Hiroyuki Kobayashi; Masumi Tsuda; Taichi Kimura; Mishie Tanino; Shunsuke Terasaka; Shinya Tanaka
Journal:  Neuro Oncol       Date:  2013-03-28       Impact factor: 12.300

Review 8.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

9.  Evolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1.

Authors:  Carolyn T A Herzig; Ray W Waters; Cynthia L Baldwin; Janice C Telfer
Journal:  BMC Evol Biol       Date:  2010-06-15       Impact factor: 3.260

10.  Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice.

Authors:  Gennadiy Kovtunovych; Manik C Ghosh; Wade Ollivierre; R Patrick Weitzel; Michael A Eckhaus; John F Tisdale; Akihiro Yachie; Tracey A Rouault
Journal:  Blood       Date:  2014-06-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.